Table 2.
Factor |
Univariate |
Multivariate |
||||||
OS |
RFS |
OS |
RFS |
|||||
HR (95%CI) | P | HR (95%CI) | P | HR (95%CI) | P | HR (95%CI) | P | |
Sex (male) | 1.487 (0.773-2.864) | 0.235 | 1.354 (0.885-2.071) | 0.163 | ||||
Age (> 60 yr) | 1.091 (0.627-1.772) | 0.723 | 1.017 (0.723-1.430) | 0.923 | ||||
HBsAg (+) | 1.275 (0.618-2.630) | 0.511 | 1.365 (0.842-2.214) | 0.207 | ||||
Total bilirubin (μmol/L) | 0.992 (0.964-1.021) | 0.586 | 0.966 (0.979-1.013) | 0.653 | ||||
Prothrombin time (s) | 1.071 (0.931-1.232) | 0.340 | 1.064 (0.966-1.173) | 0.210 | ||||
Child-Pugh classification (B) | 1.423 (0.523-3.875) | 0.490 | 2.074 (1.098-3.915) | 0.024 | ||||
Hypersplenism (yes) | 0.949 (0.477-1.887) | 0.882 | 1.158 (0.738-1.817) | 0.524 | ||||
AFP (> 400 ng/mL) | 2.063 (1.379-3.086) | 0.000 | 1.321 (1.007-1.733) | 0.044 | 1.738 (1.152-2.622) | 0.008 | ||
HBV-DNA (> 1 × 104 IU/mL) | 1.191 (0.798-1.777) | 0.393 | 1.259 (0.962-1.649) | 0.094 | 1.316 (1.002-1.729) | 0.048 | ||
Tumor size (> 5 cm) | 2.219 (1.456-3.382) | 0.000 | 1.694 (1.291-2.223) | 0.000 | 1.858 (1.213-2.848) | 0.004 | 1.600 (1.216-2.105) | 0.001 |
Nodule no. (multinodular) | 1.425 (0.885-2.294) | 0.145 | 1.370 (0.985-1.905) | 0.061 | 1.427 (1.024-1.989) | 0.036 | ||
Differentiation (grades 3-4) | 1.396 (0.934-2.085) | 0.103 | 1.347 (1.027-1.766) | 0.031 | ||||
Incomplete tumor capsule (yes) | 2.366 (1.582-3.537) | 0.000 | 1.664 (1.266-2.187) | 0.000 | 1.998 (1.329-3.006) | 0.001 | 1.468 (1.114-1.935) | 0.006 |
MVI (yes) | 3.412 (2.135-5.452) | 0.000 | 2.180 (1.646-2.888) | 0.000 | 2.524 (1.564-4.075) | 0.000 | 1.959 (1.472-2.606) | 0.000 |
Cirrhosis (yes) | 0.922 (0.522-1.541) | 0.757 | 1.359 (0.918-2.031) | 0.125 | ||||
Approach of resection (major ) | 1.576 (1.054-2.357) | 0.027 | 1.177 (0.896-1.547) | 0.242 | 1.611 (1.073-2.419) | 0.021 | ||
Hepatic inflow occlusion (yes) | 0.784 (0.519-1.185) | 0.248 | 0.919 (0.649-1.217) | 0.556 |
OS: Overall survival; RFS: Recurrence-free survival; AFP: Alpha-fetoprotein; MVI: Microvascular invasion.